drugset / Trial / NCT03087578

Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

NCT03087578

RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares electroacupuncture to mirabegron for treatment of overactive bladder (OAB) symptoms in women who have failed treatment with anticholingeric therapy.

Timeline

Start
2017-07-01
Primary completion
2018-07-01
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirabegron Other / unclassified 50 mg

Indications